Peter McNamara - Tectonic Therapeutic, Chief Officer
| TECX Stock | 47.56 0.12 0.25% |
Executive
Peter McNamara is Chief Officer of Tectonic Therapeutic,
| Age | 53 |
| Address | 490 Arsenal Way, Watertown, MA, United States, 02472 |
| Web | https://tectonictx.com |
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Sarah Connors | Karyopharm Therapeutics | N/A | |
| Roman Necina | Hookipa Pharma | 56 | |
| Carolyn JD | Arcus Biosciences | 45 | |
| Mark Winderlich | Hookipa Pharma | 38 | |
| Reigin Zawadzki | Caribou Biosciences | N/A | |
| Cindy Tahl | Fate Therapeutics | 51 | |
| Matthew Beck | Hookipa Pharma | N/A | |
| Stephen Young | Arcus Biosciences | 55 | |
| Yuko JD | Sana Biotechnology | N/A | |
| MBA MD | X4 Pharmaceuticals | 62 | |
| Stuart Poulton | Karyopharm Therapeutics | N/A | |
| Mark MBA | X4 Pharmaceuticals | 60 | |
| Pharm MPH | X4 Pharmaceuticals | N/A | |
| Brian Austad | Karyopharm Therapeutics | N/A | |
| Michael Szumera | Hookipa Pharma | N/A | |
| Daniel Poon | Caribou Biosciences | N/A | |
| Terry MD | Sana Biotechnology | 57 | |
| Gary MD | Sana Biotechnology | N/A | |
| Jim MBA | Fate Therapeutics | N/A | |
| William Grossman | Arcus Biosciences | 50 | |
| Sonja MD | Sana Biotechnology | 49 | |
Tectonic Therapeutic, Leadership Team
Elected by the shareholders, the Tectonic Therapeutic,'s board of directors comprises two types of representatives: Tectonic Therapeutic, inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tectonic. The board's role is to monitor Tectonic Therapeutic,'s management team and ensure that shareholders' interests are well served. Tectonic Therapeutic,'s inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tectonic Therapeutic,'s outside directors are responsible for providing unbiased perspectives on the board's policies.
| Daniel MBA, Chief Officer | ||
| MS MD, Chief Officer | ||
| Christian Cortis, Executive Officer | ||
| Peter McNamara, Chief Officer | ||
| Anthony MD, Chief Officer | ||
| John Diener, Senior Sciences | ||
| Marc Schwabish, Chief Officer | ||
| Marcella MD, Chief Officer | ||
| Barry MS, Senior Culture |
Tectonic Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Tectonic Therapeutic, a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Current Valuation | 83.39 M | ||||
| Shares Outstanding | 14.73 M | ||||
| Shares Owned By Insiders | 39.39 % | ||||
| Shares Owned By Institutions | 43.43 % | ||||
| Number Of Shares Shorted | 476.84 K | ||||
| Price To Book | 1.59 X | ||||
| EBITDA | (43.17 M) | ||||
| Net Income | (42.82 M) | ||||
| Total Debt | 4.34 M | ||||
| Book Value Per Share | 11.29 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Tectonic Stock Analysis
When running Tectonic Therapeutic,'s price analysis, check to measure Tectonic Therapeutic,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tectonic Therapeutic, is operating at the current time. Most of Tectonic Therapeutic,'s value examination focuses on studying past and present price action to predict the probability of Tectonic Therapeutic,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tectonic Therapeutic,'s price. Additionally, you may evaluate how the addition of Tectonic Therapeutic, to your portfolios can decrease your overall portfolio volatility.